BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Immunology Podcast - ECPv6.17.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The Immunology Podcast
X-ORIGINAL-URL:https://www.immunologypodcast.com
X-WR-CALDESC:Events for The Immunology Podcast
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230912
DTEND;VALUE=DATE:20230913
DTSTAMP:20230815T055823Z
CREATED:20230815T054339Z
LAST-MODIFIED:20230815T055823Z
UID:5327-1694476800-1694563199@www.immunologypodcast.com
SUMMARY:Dr. Kristin Anderson
DESCRIPTION:Dr. Kristin Anderson is an Assistant Professor at the University of Virginia. Her research program develops engineered T cell immunotherapies\, integrating cellular and molecular techniques with in vivo mouse models and in vitro patient-based models of solid tumors to study the complex interactions between antitumor T cells and the tumor microenvironment.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-kristin-anderson
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2023/08/Kristin-Anderson-420px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230829
DTEND;VALUE=DATE:20230830
DTSTAMP:20230823T222358Z
CREATED:20230823T222314Z
LAST-MODIFIED:20230823T222358Z
UID:5339-1693267200-1693353599@www.immunologypodcast.com
SUMMARY:Dr. Vinod Balachandran
DESCRIPTION:Dr. Vinod Balachandran is an Attending Surgeon at Memorial Sloan Kettering Cancer Center and a Member of the David. M Rubenstein Center for Pancreatic Cancer Research. His lab aims to discover new ways to stimulate the immune system to treat cancer through careful study of rare cancer patients with exceptional outcomes. They specifically focus on a rare subgroup of pancreatic cancer patients with exceptional long-term survival to discover new immunotherapeutic approaches.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-vinod-balachandran
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2023/08/Vinod-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230815
DTEND;VALUE=DATE:20230816
DTSTAMP:20230823T175156Z
CREATED:20230811T204809Z
LAST-MODIFIED:20230823T175156Z
UID:5320-1692057600-1692143999@www.immunologypodcast.com
SUMMARY:Dr. Greg Delgoffe
DESCRIPTION:Dr. Greg Delgoffe is an Associate Professor at the University of Pittsburgh. The Delgoffe lab studies the intersection of metabolism and immunity in cancer. Specifically\, they investigate how tumor cells deplete their local microenvironment of nutrients\, effectively starving tumor-infiltrating T cells and preventing their function. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-greg-delgoffe
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2023/08/Greg-Delgoffe-420-px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230801
DTEND;VALUE=DATE:20230802
DTSTAMP:20230713T221818Z
CREATED:20230713T221747Z
LAST-MODIFIED:20230713T221818Z
UID:5302-1690848000-1690934399@www.immunologypodcast.com
SUMMARY:Dr. Daniel Streicker
DESCRIPTION:Dr. Daniel Streicker is a Professor of Viral Ecology at the University of Glasgow. His lab uses a range of approaches to identify patterns in pathogen transmission between species\, and develop solutions for real-world disease problems. Current projects are investigating transmissible and transferrable vaccines for disease control in bats\, prediction of the host tropism of viruses from their genome sequences\, understanding how satellite viruses jump between host species\, and forecasting vampire bat rabies outbreaks in humans and livestock.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-daniel-streicker
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2023/07/Daniel-Streicker-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230718
DTEND;VALUE=DATE:20230719
DTSTAMP:20230712T233419Z
CREATED:20230712T233406Z
LAST-MODIFIED:20230712T233419Z
UID:5294-1689638400-1689724799@www.immunologypodcast.com
SUMMARY:Dr. Jamie Spangler
DESCRIPTION:Dr. Jamie Spangler is an Assistant Professor in the Departments of Biomedical and Chemical & Biomolecular Engineering at Johns Hopkins University. Her group aims to redesign existing proteins and engineer new proteins that overcome these limitations. Combining cutting-edge technologies from structural biophysics\, molecular engineering\, and translational immunology\, they create new platforms for the development of targeted therapeutics to treat a broad range of immune diseases.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-jamie-spangler
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2023/07/Jamie-Spangler-square-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230621
DTEND;VALUE=DATE:20230622
DTSTAMP:20230621T165009Z
CREATED:20230504T163917Z
LAST-MODIFIED:20230621T165009Z
UID:5188-1687305600-1687391999@www.immunologypodcast.com
SUMMARY:Dr. Alessandro Sette
DESCRIPTION:Dr. Alessandro Sette has devoted more than 35 years of study towards understanding the immune response\, measuring immune activity\, and developing disease intervention strategies against cancer\, autoimmunity\, allergy\, and infectious diseases. The laboratory is defining in chemical terms the specific structures (epitopes) that the immune system recognizes\, and uses this knowledge to measure and understand immune responses. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-alessandro-sette
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2023/05/Alex-Sette-square-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230509
DTEND;VALUE=DATE:20230510
DTSTAMP:20230504T183309Z
CREATED:20230504T183230Z
LAST-MODIFIED:20230504T183309Z
UID:5192-1683590400-1683676799@www.immunologypodcast.com
SUMMARY:Dr. Prasanna Jagannathan
DESCRIPTION:Dr. Prasanna Jagannathan is an Assistant Professor of Medicine at Stanford University. His research program in human immunology focuses on malaria-specific immune responses in pregnancy and infancy. His current research program is to further our understanding of the mechanisms of clinical immunity to malaria through field-based studies\, and to better understand the immunologic consequences of malaria control interventions.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-prasanna-jagannathan
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2023/05/Prasanna-Jagannathan.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230425
DTEND;VALUE=DATE:20230426
DTSTAMP:20230504T163608Z
CREATED:20230324T162322Z
LAST-MODIFIED:20230504T163608Z
UID:5061-1682380800-1682467199@www.immunologypodcast.com
SUMMARY:Dr. Joshua Brody
DESCRIPTION:Dr. Joshua Brody is the Director of the Lymphoma Immunotherapy Program at Icahn School of Medicine at Mount Sinai. the Brody Lab studies basic and applied tumor immunology for the development of cancer immunotherapies\, particularly for lymphomas and melanomas. They aim to improve cancer vaccines by priming anti-tumor responses at the tumor site of each patient (in situ vaccine). \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-joshua-brody
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2023/03/Joshua-Brody-420px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230411
DTEND;VALUE=DATE:20230412
DTSTAMP:20230412T191026Z
CREATED:20230406T190047Z
LAST-MODIFIED:20230412T191026Z
UID:5077-1681171200-1681257599@www.immunologypodcast.com
SUMMARY:Dr. Douglas Green
DESCRIPTION:Dr. Douglas Green is the Peter C. Doherty Endowed Chair of Immunology at St. Jude Children’s Research Hospital. The Green lab asks fundamental questions about the journey of cells – how do cells live and die\, and how do these processes affect the body? Their work uses multiple -omics-based approaches as well as computational tools to try to answer these questions. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-douglas-green
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2023/04/Doug-Green-square.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230328
DTEND;VALUE=DATE:20230329
DTSTAMP:20230329T213050Z
CREATED:20230309T203040Z
LAST-MODIFIED:20230329T213050Z
UID:5043-1679961600-1680047999@www.immunologypodcast.com
SUMMARY:Drs. Miriam Merad and Mark Davis
DESCRIPTION:Dr. Miriam Merad is the President and Dr. Mark Davis is a Scientific Programme Committee Co-Chair of the International Union of Immunological Societies (IUIS). This episode focuses on the upcoming 18th International Congress of Immunology taking place November 27 – December 2 in Capetown\, South Africa. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/drs-miriam-merad-and-mark-davis
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2023/03/Miriam-Merad-and-Mark-Davis.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230314
DTEND;VALUE=DATE:20230315
DTSTAMP:20230315T211456Z
CREATED:20230309T182511Z
LAST-MODIFIED:20230315T211456Z
UID:5032-1678752000-1678838399@www.immunologypodcast.com
SUMMARY:Dr. Clovis Palmer
DESCRIPTION:Dr. Clovis Palmer is an Assistant Professor at Tulane University. He uses non-human primate models to study aging\, long-COVID\, and HIV. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-clovis-palmer
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2023/03/Clovis-Palmer.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230228
DTEND;VALUE=DATE:20230301
DTSTAMP:20230225T001850Z
CREATED:20230225T001224Z
LAST-MODIFIED:20230225T001850Z
UID:5005-1677542400-1677628799@www.immunologypodcast.com
SUMMARY:Drs. Mark Davis\, Daniel Mucida\, and Shruti Naik
DESCRIPTION:Dr. Mark Davis is the President of the American Association of Immunologists and the Avery Family Professor of Immunology at Stanford University. Dr. Daniel Mucida is a Professor at Rockefeller University and Dr. Shruti Naik is an Assistant Professor at NYU Langone Medical Center.  They discuss the upcoming IMMUNOLOGY2023™ meeting in May in Washington\, D.C. \n 
URL:https://www.immunologypodcast.com/upcoming-guests/drs-mark-davis-daniel-mucida-and-shruti-naik
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2023/02/Mark-Davis-Dan-Mucida-and-Shruti-Naik-square.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230214
DTEND;VALUE=DATE:20230215
DTSTAMP:20230202T210459Z
CREATED:20230202T191541Z
LAST-MODIFIED:20230202T210459Z
UID:4959-1676332800-1676419199@www.immunologypodcast.com
SUMMARY:Dr. Hao Wu
DESCRIPTION:Dr. Hao Wu is the Asa and Patricia Springer Professor at Harvard Medical School. The Wu laboratory focuses on elucidating cellular and structural regulation in innate immune pathways\, in particular the inflammasome pathway.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-hao-wu
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2022/12/hao-wu-300x300-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221025
DTEND;VALUE=DATE:20221026
DTSTAMP:20230120T171203Z
CREATED:20220807T220256Z
LAST-MODIFIED:20230120T171203Z
UID:4052-1666656000-1666742399@www.immunologypodcast.com
SUMMARY:Drs. Robert Watson and Kristin Patrick
DESCRIPTION:Drs. Robert Watson and Kristin Patrick’s labs at Texas A&M University College of Medicine study how the macrophage innate immune response is regulated during bacterial infection.  The Watson lab studies the Mycobacterium tuberculosis host-pathogen interface\, and is particularly focused how Mtb cytosolic access and mitochondrial homeostasis impact bacterial pathogenesis in macrophages ex vivo and in mouse models of infection. The Patrick lab studies the contributions of RNA binding proteins to macrophage activation and how post-transcriptional regulation of innate immune gene expression (mostly at the level of pre-mRNA splicing) impacts infection outcomes. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/drs-robert-watson-and-kristin-patrick
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2022/08/20180209_Watsons_012-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221011
DTEND;VALUE=DATE:20221012
DTSTAMP:20230120T171228Z
CREATED:20220805T203648Z
LAST-MODIFIED:20230120T171228Z
UID:4049-1665446400-1665532799@www.immunologypodcast.com
SUMMARY:Dr. Henrique Borges da Silva
DESCRIPTION:Dr. Henrique Borges da Silva is an Assistant Professor at the Mayo Clinic in Arizona. His main research focus is determining how the extracellular nucleotide\, extracellular ATP (eATP)\, affects transcriptional\, metabolic\, and functional mechanisms of CD8-positive T cells in response to viral infections and cancer. This stems from fundamental discoveries made by Dr. Borges da Silva that showed a crucial role for the eATP purinergic receptor P2RX7 in the establishment of CD8-positive T cell memory. \nListen to the episode here. \n 
URL:https://www.immunologypodcast.com/upcoming-guests/dr-henrique-borges-da-silva
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2022/08/Borges_da_-Silva_Henrique_20A-e1673045046528.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220927
DTEND;VALUE=DATE:20220928
DTSTAMP:20230120T171253Z
CREATED:20220805T201817Z
LAST-MODIFIED:20230120T171253Z
UID:4047-1664236800-1664323199@www.immunologypodcast.com
SUMMARY:Dr. Indira Mysorekar
DESCRIPTION:Dr. Indira Mysorekar is a Professor of Medicine and Chief of Basic and Translational Research at Baylor College of Medicine. She is a cell and developmental biologist with extensive training in host-microbial interactions at two distinct tissues: the urinary bladder and placenta. Her lab uses mouse and cell culture models and conducts translational studies to ask key questions about these tissues. Her research work encompasses studies of UTIs and fundamental mechanisms of urinary bladder development and homeostasis\, as well as preterm birth and in utero transmission of Zika virus. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-indira-mysorekar
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2022/08/Indira-Mysorekar-square-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220913
DTEND;VALUE=DATE:20220914
DTSTAMP:20240924T220648Z
CREATED:20220901T181429Z
LAST-MODIFIED:20240924T220648Z
UID:4068-1663027200-1663113599@www.immunologypodcast.com
SUMMARY:Drs. Ruth Ley and Sara Clasen
DESCRIPTION:Dr. Ruth Ley is the Managing Director and Dr. Sara Clasen is a Postdoctoral Fellow at the Max Planck Institute for Developmental Biology Tübingen. Dr. Ley’s lab uses basic science to investigate the evolutionary history of gut microbes\, how they have adapted to life inside humans\, and how they affect human biology and health. Dr. Clasen’s research focuses on flagellin-TLR5 interactions. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/drs-ruth-ley-and-sara-clasen
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2022/08/Ruth-Ley-and-Sara-Clasen.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220830
DTEND;VALUE=DATE:20220831
DTSTAMP:20230120T171347Z
CREATED:20220805T200437Z
LAST-MODIFIED:20230120T171347Z
UID:4043-1661817600-1661903999@www.immunologypodcast.com
SUMMARY:Dr. Leonardo Ferreira
DESCRIPTION:Dr. Leonardo Ferreira is an Assistant Professor of Microbiology and Immunology at the Medical University of South Carolina. The Ferreira lab uses CARs and other engineered immune receptors to dissect how specificity\, affinity\, and signaling modulate the function of different T cells subsets in tolerance and immunity. Their goal is to design and develop engineered immune cell therapies for autoimmune disease\, cancer\, and aging. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-leonardo-ferreira
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2022/08/Leonardo-Ferreira-square.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220816
DTEND;VALUE=DATE:20220817
DTSTAMP:20230120T171741Z
CREATED:20220529T184859Z
LAST-MODIFIED:20230120T171741Z
UID:3990-1660608000-1660694399@www.immunologypodcast.com
SUMMARY:Dr. Karen Edelblum
DESCRIPTION:Dr. Karen Edelblum is an Assistant Professor and Chancellor Scholar at the Center for Immunity and Inflammation at Rutgers New Jersey Medical School. Her lab studies immune/epithelial interactions to better understand the underlying causes of Crohn’s disease and discover potential new areas for therapeutic development. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-karen-edelblum
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2022/05/2021-KLE-headshot.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220802
DTEND;VALUE=DATE:20220803
DTSTAMP:20230120T171728Z
CREATED:20220714T233525Z
LAST-MODIFIED:20230120T171728Z
UID:3993-1659398400-1659484799@www.immunologypodcast.com
SUMMARY:Dr. Jonathan Kipnis
DESCRIPTION:Dr. Jonathan Kipnis is a BJC Investigator\, Alan A. and Edith L. Wolff Distinguished Professor of Pathology and Immunology\, and Professor of Neurology\, Neuroscience and Neurosurgery at Washington University School of Medicine in St. Louis. The Kipnis lab studies complex interactions between the immune and nervous systems. Their goal is to elucidate the cellular and molecular mechanisms underlying nervous and immune system interactions in neurodegenerative\, neurodevelopmental and mental disorders as well as in physiology (healthy aging). Dr. Kipnis is best known for his lab’s discovery of meningeal lymphatic vessels in humans and mice. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-jonathan-kipnis
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2022/05/Jonathan-Kipnis-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220719
DTEND;VALUE=DATE:20220720
DTSTAMP:20230120T171716Z
CREATED:20220529T183446Z
LAST-MODIFIED:20230120T171716Z
UID:3985-1658188800-1658275199@www.immunologypodcast.com
SUMMARY:Dr. Mark Kaplan
DESCRIPTION:Dr. Mark Kaplan is the Chair of the Department of Microbiology and Immunology at Indiana University School of Medicine. He is currently the Editor-In-Chief for the new American Association of Immunologists journal ImmunoHorizons. Much of Dr. Kaplan’s work has focused on understanding the function of transcription factors in the development of T helper cell subsets. He has a long standing interest in Signal Transducer and Activator of Transcription or STAT proteins that are activated downstream of cytokines. His more recent work has made great progress towards understanding the development and function of IL-9-secreting T cells in the development of allergic inflammation. Ongoing interests lie in understanding how T cell subsets contribute to allergic and autoimmune inflammation. Developing projects include the contribution of IL-9 signaling to allergic inflammation and to the tumor microenvironment. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-mark-kaplan
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2022/05/Kaplan-Mark-11-web.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220705
DTEND;VALUE=DATE:20220706
DTSTAMP:20230120T171702Z
CREATED:20220511T185139Z
LAST-MODIFIED:20230120T171702Z
UID:3963-1656979200-1657065599@www.immunologypodcast.com
SUMMARY:Dr. Laura Mackay
DESCRIPTION:Dr. Laura Mackay is a Laboratory Head at the Peter Doherty Institute for Infection and Immunity at The University of Melbourne and holds an Adjunct appointment at the Singapore Immunology Network at A*STAR in Singapore. Her laboratory studies memory T cell responses\, with a focus on the signals that control tissue-resident memory T cell differentiation\, with a view to harness these cells to develop new treatments against infection and cancer. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-laura-mackay
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2022/05/Laura-Mackay-square-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220621
DTEND;VALUE=DATE:20220622
DTSTAMP:20230120T171648Z
CREATED:20220620T071016Z
LAST-MODIFIED:20230120T171648Z
UID:4012-1655769600-1655855999@www.immunologypodcast.com
SUMMARY:Dr. Mark Shlomchik
DESCRIPTION:Dr. Mark Shlomchik is a UPMC Endowed and Distinguished Professor and Chair of the Department of Immunology at the University of Pittsburgh. He is also a Founder and Chief Scientific Officer of BlueSphere Bio\, a company working to create individualized T cell therapy for the treatment of cancer. Dr. Shlomchik’s lab focuses on systemic autoimmune diseases\, long-lived B-cell immunity\, and immunopathogenesis. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-mark-shlomchik
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2022/06/Mark-Shlomchik-square-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220607
DTEND;VALUE=DATE:20220608
DTSTAMP:20230120T171634Z
CREATED:20220525T183149Z
LAST-MODIFIED:20230120T171634Z
UID:3977-1654560000-1654646399@www.immunologypodcast.com
SUMMARY:Dr. Hanover Matz
DESCRIPTION:Dr. Hanover Matz is a Postdoctoral Researcher at the University of Maryland. His PhD research focused mainly on the basic biology of the shark B cell response\, and how the humoral immune system evolved in vertebrates. He also uses the IgNAR immunoglobulin isotype in sharks to address applied questions\, primarily generating shark antibodies as diagnostic/therapeutic tools. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-hanover-matz
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2022/05/Matz_headshot-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220524
DTEND;VALUE=DATE:20220525
DTSTAMP:20230120T171620Z
CREATED:20220407T161940Z
LAST-MODIFIED:20230120T171620Z
UID:3902-1653350400-1653436799@www.immunologypodcast.com
SUMMARY:Dr. Michael Alonso
DESCRIPTION:Dr. Michael Alonso is a Scientific Co-Founder\, and Vice President of Immunology & Pharmacology at Bolt Biotherapeutics\, a biotechnology company developing immunotherapies that activate myeloid cells. This includes immune-stimulating antibody conjugates (ISAC)\, which reprogram the tumor microenvironment to invoke a new anti-tumor immune response. Dr. Alonso has a PhD in Immunology from Stanford University School of Medicine\, where his research demonstrated that activated T cells dictate the nature of the immune response by instructing monocytes to differentiate into specialized dendritic cell subsets. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-michael-alonso
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2022/04/Michael-Alonso.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220510
DTEND;VALUE=DATE:20220511
DTSTAMP:20230120T171605Z
CREATED:20220507T153104Z
LAST-MODIFIED:20230120T171605Z
UID:3942-1652140800-1652227199@www.immunologypodcast.com
SUMMARY:Dr. Alice Long
DESCRIPTION:Dr. S. Alice Long is an Associate Member of the Center for Translational Immunology at Benaroya Research Institute at Virginia Mason. The Long lab is focused on understanding how tolerance is lost in autoimmunity. Gaining a better understanding of the disease-related causes and consequences of defective cytokine signaling may lead to development of more sensitive biomarkers and more targeted therapies that promote tolerance. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-alice-long
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2022/05/Headshot-Long-S.-Alice.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220508
DTEND;VALUE=DATE:20220509
DTSTAMP:20230120T171551Z
CREATED:20220507T152455Z
LAST-MODIFIED:20230120T171551Z
UID:3939-1651968000-1652054399@www.immunologypodcast.com
SUMMARY:Dr. Shruti Naik
DESCRIPTION:Dr. Shruti Naik is an Assistant Professor of Biological Sciences at NYU Langone. She studies immunity in the epithelial tissues that line our body to understand how environmental stimuli collaborate with genetic factors to influence health and drive disease at these interfaces. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-shruti-naik
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2022/05/naiks06-hero.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220506
DTEND;VALUE=DATE:20220507
DTSTAMP:20230120T171538Z
CREATED:20220506T204752Z
LAST-MODIFIED:20230120T171538Z
UID:3936-1651795200-1651881599@www.immunologypodcast.com
SUMMARY:Dr. Gwendalyn Randolph
DESCRIPTION:Dr. Gwendalyn Randolph is the Emil R. Unanue Distinguished Professor in the Department of Immunology and Pathology at Washington University in St. Louis. Research in her lab integrates the study of monocytes\, monocyte-derived cells\, and dendritic cells with vascular and lymphatic vessel biology. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-gwendalyn-randolph
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2022/05/Gwendalyn-Randolph.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220426
DTEND;VALUE=DATE:20220427
DTSTAMP:20230120T171949Z
CREATED:20220310T204418Z
LAST-MODIFIED:20230120T171949Z
UID:3859-1650931200-1651017599@www.immunologypodcast.com
SUMMARY:Dr. Michael Rosenblum
DESCRIPTION:Dr. Michael Rosenblum is a Professor of Dermatology at the University of California\, San Francisco. The central focus of his lab’s research is to understand how immune responses are regulated in tissues and how this knowledge can be exploited for therapeutic benefit. They are currently investigating how regulatory T cells (Tregs) control immune responses in tissues\, and their “alternative” functions. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-michael-rosenblum
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2022/03/Rosenblum-Headshot-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220412
DTEND;VALUE=DATE:20220413
DTSTAMP:20230120T172001Z
CREATED:20220330T235933Z
LAST-MODIFIED:20230120T172001Z
UID:3893-1649721600-1649807999@www.immunologypodcast.com
SUMMARY:Dr. Gary Koretzky
DESCRIPTION:Dr. Gary Koretzky is the President of the American Association of Immunologists (AAI). He is also the Vice Provost for Academic Integration at  Cornell University\, Professor of Medicine at Weill Cornell Medicine\, and Director of the Cornell Center for Immunology. This will be a special episode focused on the upcoming AAI 2022 meeting. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-gary-koretzky
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2022/03/Gary-Koretzky-square.png
END:VEVENT
END:VCALENDAR